Antidiabetic effects afforded by terminalia arjuna in high fat-fed and streptozotocin-induced type 2 diabetic rats

International Journal of Diabetes and Metabolism

Volumn 19, Issue 1, 2011, Pages 23-33

  Parveen, Kehkashan ^a   Khan, Rashid ^a   Siddiqui, Waseem A ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Hyperglycemia; Lipid peroxidation; Oxidative stress; Terminalia arjuna; Type 2 diabetes mellitus

Indexed keywords

ALKALINE PHOSPHATASE; CARBONYL DERIVATIVE; CATALASE; CHOLESTEROL; CREATININE; GLUCOSE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLYCOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITROGEN; STREPTOZOCIN; TERMINALIA ARJUNA EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UREA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG ACTIVITY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HYPERGLYCEMIA; HYPERLIPIDEMIA; LIPID COMPOSITION; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

EID: 80051632635     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Papas MA. Determinants of antioxidant status in humans. Lipids 1996; 31: 77-82.
2. Agarwal S, Sohal RS. Relationship between aging and susceptibility to protein oxidative damage. Biochem Biophys Res Commun 1993; 194: 1203-1206.
3. Adachi H, Fujiwara Y, Ishii N. Effects of oxygen on protein carbonyl and aging in Caenorhabditis elegans mutants with long (age-1) and short (mev-1) life spans. J Gerontol A Biol Sci Med Sci 1998; 53: 240-244.
4. Aksenova MV, Aksenov MY, Carney JM, Butterfield DA. Protein oxidation and enzyme activity decline in old brown Norway rats are reduced by dietary restriction. Mech Ageing Dev 1998; 100: 157-168.
5. Chandra M, Chandra N, Agrawal R, Kumar A, Ghatak A, Pandey VC. The free radical system in ischemic heart disease. Int J Cardiol 1994; 43: 121-125.
6. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications. A new perpective on an old paradigm. Diabetes 1999; 48: 1-9.
7. Kuyvenhoven JP, Meinders AE. Oxidative stress and diabetes mellitus. Pathogenesis of long-term complications. Eur J Intern Med 1999; 10: 9-19.
8. Maritim A, Dene BA, Sanders RA, Watkins III JB. Effects of Pycnogenol treatment on oxidative stress in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2003; 17: 193-199.
9. Tierney LM, McPhee SJ, Papadakis MA. Current medical Diagnosis & Treatment. Int edition. New York: Lange Medical Books/McGraw-Hill, 2002: 1203-1215.
10. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 2004; 47: 31-39.
11. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signaling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7: 85-96.
12. Hellestrom C. Growth pattern of pancreatic islets in animals. In: Volk BV, Wellman KE, eds. The diabetic pancreas, 1st edn. New York: Plenum Medical Book Co, 1977; 61-97.
13. Ferre T, Pujol A, Riu E, Bosch F, Valera A. Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci USA 1996; 93: 7225-7230.
14. Pari L, Latha M. Effectof Scoparia dulcis (Sweet Broomweed) plant extract on plasma antioxidants in streptozotocin-induced experimental diabetes in male albino Wistar rats. Pharmazie 2004; 59: 557-560.
15. Islam MS, Choi H, Loots du T. Effects of dietary onion (Allium cepa L.) in a high-fat diet streptozotocin-induced diabetes rodent model. Ann Nutr Metab 2008; 53: 6-12.
16. Dwivedi S, Udupa N. Terminalia arjuna: pharmacognosy, phytochemistry, pharmacology and clinical use - a review. Fitoterapia 1989; 60: 413-420.
17. Hartwell JL. In: Plants Used Against Cancer. A Survey, Lawrence MA: Quarterman, 1982; 89-93.
18. Parmar HS, Panda S, Jatwa R, Kar A. Cardio-protective role of Terminalia arjuna bark extract is possibly mediated through alterations in thyroid hormones. Pharmazie 2006; 61: 793-795.
19. Vaidyaratnam PS. 1994. Varier's Indian Medicinal Plants, A Compendium of 500 Species. Orient Longman: Arya Vaidya Sala Kottakal, 1994; 3: 423.
20. Rane MM, Mengi SA. Comparative effect of oral administration and topical application of alcoholic extract of Terminalia arjuna bark on incision and excision wounds in rats. Fitoterapia 2003; 74: 553-558.
21. Chaudhari M, Mengi S. Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats. Phytother Res 2006; 20: 799-805.
22. Manna P, Sinha M, Sil PC. Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Complement Altern Med 2006; 6: 33.
23. Sivalokanathan S, Ilayaraja M, Balasubramanian MP. Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Mol Cell Biochem 2006; 281: 87-93.
24. Sivalokanathan S, Vijayababu MR, Balasubramanian MP. Effects of Terminalia arjuna bark extract on apoptosis of human hepatoma cell line Hep G2. World J Gastroenterol 2006b; 12: 1018-1024.
25. Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J 1997; 49: 507-510.
26. Manonmani G, Anbarasi K, Balakrishna K, Veluchamy G, Shyamala Devi CS. Effect of Terminalia arjuna on the antioxidant defense system in alloxan induced diabetes in rats. Biomedicine 2002; 22: 52-61.
27. Raghavan B, Kumari SK. Effect of Terminalia arjuna stem bark on antioxidant status in liver and kidney of alloxan diabetic rats. Indian J Physiol Pharmacol 2006; 50: 133-142.
28. Reed MJ, Meszaros K, Entes, LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000; 49: 1390-1394.
29. Seifter S, Dayton S, Noyic B, Muntwyler E. Estimation of glycogen with anthrone reagent. Arch Biochem 1950; 25: 191.
30. Bessey OA, Lowry OH, Brock MJ. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem 1946; 164: 321-329.
31. Utley HC, Bernheim F, Hochslein P. Effect of sulfhydryl reagent on peroxidation in micrisome. Arch Biochem Biophys 1967; 260; 521-531.
32. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
33. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER.Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-78.
34. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacol 1974; 11: 151-169.
35. Habig WH, Pabst M, Jakoby WB. Glutathion-S-transferase: The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
36. Claiborne A. Catalase activity. In: Green Wald RA, eds. Handbook of Methods for Oxygen radical Research. Boca Raton FL: CRC Press, 1985; 283-284.
37. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
38. Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997; 46: S38-S42.
39. Elgawish A, Glomb M, Freelander M, Monnier VM. Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem 1996; 271: 12964-12971.
40. Bollen M, Keppens S, Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J 1998; 336: 19-31.
41. Tan BK, Tan CH, Pushparaj PN. Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats. Life Sci 2005; 76: 2827-2839.
42. Goldberg RB. Lipid disorders in diabetes, Diabetes Care 1981; 4: 561-572.
43. Im SJ, Kim GJ. Hypoglycemic effect of Polygonatum odoratum var. pluriflorum ohwi extract in streptozotocin-induced diabetic rats. Korean J Nutr 1995; 28: 727-736.
44. Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich JE. Renal glucose production and utilization: new aspects in humans. Diabetologia 1997; 40: 749-757.
45. ® prevents potassium dichromate (K2Cr2O7)-induced oxidative damage and nephrotoxicity in rats. Chem Biol Interact 2009; 181: 343-350.
46. Salminen, Vihko V. Lipid peroxidation in exercise myopathy. Exp Mol Pathol 1983; 38: 380-388.
47. Ilhan N, Halifeoglu I, Ozercan HI. Tissue malondialdehyde and adenosine triphosphatase level after experimental liver ischaemia-reperfusion damage. Cell Biochem Funct 2001; 19: 207-212.
48. Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation:protein carbonyl content as a markerofdamage. Free Radic Res 2000; 33: S99-S108.
49. McLennan SV, Heffernan S, Wright L, Rae C, Fisher E, Yue DK, Turtle JR. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991; 40: 344-348.
50. Bone K. Clinical Applications of Ayurvedic and Chinese Herbs. Phytotherapy Press; 1996:131-133.
51. Kapoor LD. Handbook of Ayurvedic Medicinal Plants. Boca Raton FL: CRC Press, 1990; 319-320.